Nicholas P Daniel, Garrahy Ian
Department of Internal Medicine, Reading Hospital and Medical Center, Tower Health, West Reading, PA, USA.
J Community Hosp Intern Med Perspect. 2019 Dec 14;9(6):507-510. doi: 10.1080/20009666.2019.1688125. eCollection 2019.
Minimal Change Disease (MCD) is identified via renal biopsy as the etiology of nephrotic syndrome in a minority of adult cases; however, a significant proportion of these occurrences are accompanied by acute kidney injury (AKI). Risk factors for AKI in MCD include increased age, male sex, hypertension, and marked proteinuria and hypoalbuminemia. The etiology of AKI appears to be tubular injury as demonstrated with biomarkers, and although it is usually reversible with steroid therapy, resistance and relapses can occur and may require the use of second-line agents. We present a case of an adult patient with acute onset of biopsy-proven MCD and AKI demonstrating a partial response to corticosteroids and aggressive diuresis and later relapsing and requiring further immunosuppression with tacrolimus. Ultimately, further studies are required to determine the optimal treatment regimen for MCD to ensure remission and avoid relapse.
微小病变性肾病(MCD)经肾活检确定为少数成人肾病综合征病例的病因;然而,这些病例中有很大一部分伴有急性肾损伤(AKI)。MCD患者发生AKI的危险因素包括年龄增加、男性、高血压、显著蛋白尿和低白蛋白血症。生物标志物显示,AKI的病因似乎是肾小管损伤,虽然通常用类固醇治疗可逆转,但可能会出现耐药和复发,可能需要使用二线药物。我们报告一例成年患者,其经活检证实为急性起病的MCD和AKI,对皮质类固醇和积极利尿治疗有部分反应,随后复发,需要用他克莫司进行进一步免疫抑制治疗。最终,需要进一步研究以确定MCD的最佳治疗方案,以确保缓解并避免复发。